The largest database of trusted experimental protocols

363 protocols using galactose

1

Carbohydrate Standards Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The substrates fructose, glucose,
sucrose, galactose, and PEI with 98% purity were purchased from Sigma-Aldrich.
The organic solvents IPA and ethyl acetate were commercial grade organic
solvents (purity >99%) and used without further purification. The
5-HMF, fructose, glucose, sucrose, and galactose standards were purchased
from Sigma-Aldrich. All the solvents and chemicals used for high-pressure
liquid chromatography (HPLC) analysis are analytical grade chemicals
and solvents.
+ Open protocol
+ Expand
2

Galactose-Mediated Transfection of Hep3B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 6

Hep3B cells were seeded onto 24-well plates at a density of 1×105 cells per well. After 24 h, the cells were pre-incubated with 2 mg/ml of Galactose (Sigma Aldrich, Singapore) in 500 μL of fresh media per well for 1 h before 50 μL of Galactose-functionalized bPEI/DNA complexes were added and allowed to transfect for 4 h. After the 4 h incubation, the transfection medium was replaced with fresh media and the luciferase expression levels were analysed as described above after a further incubation of 68 h.

It will be apparent that various other modifications and adaptations of the invention will be apparent to the person skilled in the art after reading the foregoing disclosure without departing from the spirit and scope of the invention. It is intended that all such modifications and adaptations come within the scope of the appended claims. Further, it is to be appreciated that features from various embodiment(s), may be combined to form one or more additional embodiments.

+ Open protocol
+ Expand
3

Galactose Supplementation Enhances UDP-Galactose

Check if the same lab product or an alternative is used in the 5 most similar protocols
Galactose (Sigma-Aldrich) was added to fibroblast culture medium to increase the concentration of intracellular UDP-Galactose by means of the galac-tose-1-phosphate uridyltransferase (GALT) reaction (Fig. 2). The concentration used was 0.5 mM.
+ Open protocol
+ Expand
4

Modulating Oxidative Phosphorylation in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For inhibition of oxidative phosphorylation, explants were cultured for 24 hours in DM with 35 mM glucose. Immediately prior to imaging, media was exchanged with DM with PBS vehicle, Oligomycin (Sigma), or Bongkrekic Acid (Enzo Life Sciences). We found a strain difference in response to treatment to BA. CD1 cells were treated with 0.5, 2.5, 5, and 50 μM BA, while Ant1+/+ and Ant1−/− were treated with 0.5 fM BA. For glucose deprivation and inhibition experiments, explants were cultured for 24 hours in glucose free DMEM (Invitrogen) plus N2 supplement (Gibco) with or without 10 mM sodium pyruvate (Sigma) or 5 mM Galactose (Sigma), +/− 2.5 μM BA. For treatment with 2-DG, explants were cultured for 24 hours with 5 mM glucose DM supplemented with 500 μM 2-DG (Sigma), with or without 10 mM sodium pyruvate or 5 mM Galactose +/− 0.5 μM BA.
+ Open protocol
+ Expand
5

Lectin Binding Assay with Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before addition to cells, pairs of lectins and PE-conjugated streptavidin (for detection of biotin-conjugated MAAII or PNA) were combined at 10 μg/mL each in PBS (lectin working solution). For inhibition of lectin binding to cells by galactose and fetuin (Sigma Aldrich, Saint Louis, MO, USA), lectin working solution was prepared in 100 mM galactose or 0.1 mM fetuin in PBS. Thirty-five microliters of lectin working solution was then added to cells and incubated for 60 min at 4 °C. Cells were washed once with 1 mL of PBS, resuspended in 0.5 mL of the same buffer, and analyzed immediately in an Attune™ flow cytometer (blue/red lasers) from Thermo Fisher Scientific (Carlsbad, CA, USA). For neuraminidase treatment, 30 μL of neuraminidase type V from Clostridium perfringens (Sigma Aldrich) stock solution (6.1 U/mL) was added to the corresponding cells and incubated for 1.5 h at 37 °C, 5% CO2. Cells were washed with 1 mL of PBS before staining.
Unlabeled cells, single-green and single-red labeled cells were used to set up voltage and compensation settings. Double-labeled cells were then analyzed under the same conditions. Regions of viable cells in FSC-H vs. SSC-H were depicted, and green and red fluorescence was determined.
+ Open protocol
+ Expand
6

ITLN1 Silencing in BEAS-2B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BEAS-2B cells (CRL-9609, American Type Culture Collection) were cultured in DMEM/high glucose (HyClone) in 6-well plates. When cells were 90% confluent, 4 μg hITLN1 shRNA or scrambled shRNA plasmid in 250 μl of Opti-MEMI medium was mixed with 10 μl lipofectamine 2000 (Invitrogen) diluted in 240 μl of medium and added to each well. Six hours later, the media were substituted with DMEM with or without HDM (25 μg/ml; Greer Lab). At the indicated time points, cells were harvested for quantitative RT-PCR and Western blotting, and the media were collected for ELISA. The sequence of ITLN1 shRNA (sense strand) was: 5′-GCATCTTATTACTCACCCTATCTCGAGATAGGGTGAGTAATAAGATGC-3′. The sequence of scrambled shRNA (sense strand) was: 5′-GCCCATTCTTATCATACTCATCTCGAGATGAGTATGATAAGAATGGGC-3′.
For inhibition of ITLN with galactose, galactose (Sigma) was added to the medium (final concentration 30 mM) 1 h before HDM stimulation. EGFR inhibitor PD153035 (Selleck, final concentration 5μM) and AG1478 (Selleck, final concentration 10μM), and MEK inhibitor U0126 (Selleck, final concentration 10μM) were added to the medium 1 h before HDM stimulation.
+ Open protocol
+ Expand
7

ITLN1 Silencing in BEAS-2B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BEAS-2B cells (CRL-9609, American Type Culture Collection) were cultured in DMEM/high glucose (HyClone) in 6-well plates. When cells were 90% confluent, 4 μg hITLN1 shRNA or scrambled shRNA plasmid in 250 μl of Opti-MEMI medium was mixed with 10 μl lipofectamine 2000 (Invitrogen) diluted in 240 μl of medium and added to each well. Six hours later, the media were substituted with DMEM with or without HDM (25 μg/ml; Greer Lab). At the indicated time points, cells were harvested for quantitative RT-PCR and Western blotting, and the media were collected for ELISA. The sequence of ITLN1 shRNA (sense strand) was: 5′-GCATCTTATTACTCACCCTATCTCGAGATAGGGTGAGTAATAAGATGC-3′. The sequence of scrambled shRNA (sense strand) was: 5′-GCCCATTCTTATCATACTCATCTCGAGATGAGTATGATAAGAATGGGC-3′.
For inhibition of ITLN with galactose, galactose (Sigma) was added to the medium (final concentration 30 mM) 1 h before HDM stimulation. EGFR inhibitor PD153035 (Selleck, final concentration 5μM) and AG1478 (Selleck, final concentration 10μM), and MEK inhibitor U0126 (Selleck, final concentration 10μM) were added to the medium 1 h before HDM stimulation.
+ Open protocol
+ Expand
8

Quantifying Ethanol Production from Diverse Sugars

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fermentation capacities were analyzed quantitatively by ethanol determination. One isolated strain (Mi4) was inoculated in culture media (3.0 g/L of yeast extract (Difco Laboratories, Detroit, MI, USA) and 5.0 g/L of proteose peptone No. 3 (Difco Laboratories, Detroit, MI, USA) with different carbon sources: galactose (1%) or lactate (1%) plus galactose (1%) or sucrose (1%) (Sigma Aldrich Chemie, Steinheim, Germany). After seven days the ethanol produced was measured with Enzytec fluid Ethanol purchased from R-Biopharm, Darmstadt, Germany (Cat. No. E5340), following the instructions supplied by the manufacturer.
+ Open protocol
+ Expand
9

Optimizing Antimicrobial Efficacy through Metabolite Supplementation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Distilled sterile water was used for water-soluble molecules, including glutathione (Sigma-Aldrich), galactose (Sigma-Aldrich), and succinic acid (VWR Chemicals). galactose, L-aspartic acid, and acylases I were dissolved in 0.9 M NaCl, 2 M NaOH, and 100 mM potassium phosphate buffer, pH 7, respectively, according to the manufacturer's recommendations (Sigma-Aldrich). Concentrated solutions of the compounds were prepared and applied to ASM cultures to obtain a final concentration of 20 mM of aspartic acid, succinic acid, and galactose, 10 mM of glutathione, and 5 and 15 mg/L of acylases I as described in literature (Xu et al., 2003 (link); Sauer et al., 2004 (link); Klare et al., 2016 (link); Bahamondez-Canas and Smyth, 2018 (link)). All stock solutions were freshly prepared before their application on ASM. Three different concentrations of ciprofloxacin, two subinhibitory concentrations and one inhibitory concentration according to the MIC values obtained for the P. aeruginosa strains, were combined with the compounds.
+ Open protocol
+ Expand
10

Yeast Growth and Transformation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
YPAD media consisted of 1% Yeast Extract (BD, USA-212750), 2% Peptone (BD, USA-244620), 2% Dextrose (Fisher, USA-50-99-7), and 35 mg/L Adenine (Sigma, USA-A9126). Strains transformed with plasmid were grown in selective SD media containing 0.67% Yeast nitrogen base (BD, USA-233520), 2% Dextrose as a carbon source with required amino acids, 100 mg/L Adenine. For the galactose inducible system, SGal media containing 2% galactose (Sigma, USA-G0625) and 2% Raffinose (Sigma, USA-R0250) as carbon sources was used. For induction, the cells were grown in SD media until log phase, washed three times with sterile distilled water, and sub-cultured in SGal media. For induction of autophagy, transformants were grown in selective SD media until mid-log phase, washed 3–4 times with sterile distilled water, and transferred into media lacking ammonium sulfate (Sigma, USA-A4915).
For the yeast transformation experiments, all required strains were grown in liquid media until mid-log phase (~0.8 O.D.600nm). The cell density was normalized using O.D.600nm, and approximately-equal number of cells were used for transformation. Approximately 500 ng of plasmid was transformed using the PEG/LiAc method. Similar conditions were maintained for all strains during transformation. The images of transformants shown are representative of the entire plate.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!